Insights Center
Thought leadership, news, events — you will find them all here, right at your fingertips. We’ve consolidated the firm’s most popular content in one, easy to search location. Enter a key word or phrase to find pertinent blog posts, articles, press releases, and upcoming events.
Mintz Direct
Mintz Viewpoints
Showing 4825 - 4832 of 12011 results
HHS Proposes Sweeping Changes to Anti-Kickback Statute and Stark Law
October 10, 2019| Blog| Viewpoint
Connecticut Court Says Intervention Is One Way To Preserve Putative Class Member's Right To Opt Out
October 10, 2019| Blog| Viewpoint
Collateral estoppel does not attach to PTAB invalidity determination pending appeal
October 10, 2019| Blog| Viewpoint
BREAKING NEWS: California AG Issues Draft CCPA Regulations
October 10, 2019| Blog| Viewpoint
Ruling Provides Clarity in Settlement/Assignments
October 10, 2019| News
FDA Updates Digital Health Guidances to Align with 21st Century Cures Act
October 9, 2019| Blog| Viewpoint
Venture Debt 101: A Discussion of the Basics and Key Considerations
October 9, 2019| Podcast| Viewpoint
INSIGHT: Easing Conflicts When Hiring in a Family Business
October 8, 2019| News
News & Press Releases
Mintz advised The Eagle Leasing Company, a leading provider of portable storage containers, ground level offices, semi-trailers, and mobile office solutions, in its acquisition by Rent-A-Container (RAC), a portfolio company of Kinderhook Industries, LLC.
Mintz’s Life Sciences practice has been shortlisted in multiple categories for the 2025 LMG Life Sciences Americas Awards. The winners will be announced at an awards ceremony in New York on September 4. In the United States, Mintz was shortlisted in the “Venture Capital Firm of the Year” category. In Canada, Mintz was shortlisted in the “Financial & Corporate Firm of the Year” and “Patent Strategy Firm of the Year” categories.
Mintz advised ArriVent BioPharma, Inc., a clinical-stage biopharmaceutical company dedicated to the identification, development, and commercialization of differentiated medicines to address the unmet medical needs of patients with cancers, on a $75 million underwritten public offering of 2,482,692 shares of its common stock and pre-funded warrants to purchase up to 1,363,469 shares of its common stock. The common stock is listed on The Nasdaq Global Market under the symbol “AVBP.“
Events
Mintz x The Engine: Supercharging Your IP Strategy with Trade Secrets
The Engine, 750 Main St. Cambridge, MA 02139
Podcasts
Health Law Diagnosed – Best Practices for Communicating with the FDA
July 9, 2025| Podcast|
Mintz On Air: Practical Policies – An Abridged Guide to Crisis Management
July 1, 2025| Podcast|